Company profile APLS

Apellis Pharmaceuticals Inc
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh).... apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy. Show More
Quarter analysis & expected interest

There is not enough data for Apellis Pharmaceuticals -stock to provide analysis

Correlation between past revenue and Apellis Pharmaceuticals -stock search interest

There is not enough data for Apellis Pharmaceuticals -stock to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Apellis Pharmaceuticals -stock to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Apellis Pharmaceuticals login to provide analysis

Correlation between past revenue and Apellis Pharmaceuticals login search interest

There is not enough data for Apellis Pharmaceuticals login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Apellis Pharmaceuticals login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Apellis Pharmaceuticals careers to provide analysis

Correlation between past revenue and Apellis Pharmaceuticals careers search interest

There is not enough data for Apellis Pharmaceuticals careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Apellis Pharmaceuticals careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 15:36:05.

After 39 days of this quarter the interest is at 39.0. Based on that we can calculate that during remaining 52 days it will total up to 91.0.
Apellis Pharmaceuticals news expected interest is significantly higher compared to same quarter last year (+89.6%) but similar to previous quarter.

YearQ1Q2Q3Q4
20190
74
inf% QoQ
210
183.8% QoQ
48
-77.1% QoQ
2020 129
inf% YoY 168.8% QoQ
68
-8.1% YoY -47.3% QoQ
135
-35.7% YoY 98.5% QoQ
74
54.2% YoY -45.2% QoQ
2021 88
-31.8% YoY 18.9% QoQ
68
0.0% YoY -22.7% QoQ
0
-100.0% YoY -100.0% QoQ
58
-21.6% YoY inf% QoQ
2022 74
-15.9% YoY 27.6% QoQ
68
0.0% YoY -8.1% QoQ
160
inf% YoY 135.3% QoQ
78
34.5% YoY -51.2% QoQ
2023 48
-35.1% YoY -38.5% QoQ
78
14.7% YoY 62.5% QoQ
53
-66.9% YoY -32.1% QoQ
114
46.2% YoY 115.1% QoQ
2024 39
-18.8% YoY -65.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Apellis Pharmaceuticals news search interestLast update: February 09 2024 15:36:04.
Correlation coefficient between keyword and revenue is -0.05
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 15:36:06.

The average 5 years interest of Apellis Pharmaceuticals news was 6.38 per week.
The last year interest of Apellis Pharmaceuticals news compared to the last 5 years has changed by -5.33%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -31.91%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 15:36:12.

After 39 days of this quarter the interest is at 96.0. Based on that we can calculate that during remaining 52 days it will total up to 224.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
20190
203
inf% QoQ
35
-82.8% QoQ
0
-100.0% QoQ
2020 46
inf% YoY inf% QoQ
16
-92.1% YoY -65.2% QoQ
26
-25.7% YoY 62.5% QoQ
199
inf% YoY 665.4% QoQ
2021 94
104.3% YoY -52.8% QoQ
317
1881.2% YoY 237.2% QoQ
291
1019.2% YoY -8.2% QoQ
250
25.6% YoY -14.1% QoQ
2022 204
117.0% YoY -18.4% QoQ
161
-49.2% YoY -21.1% QoQ
376
29.2% YoY 133.5% QoQ
307
22.8% YoY -18.4% QoQ
2023 308
51.0% YoY 0.3% QoQ
275
70.8% YoY -10.7% QoQ
251
-33.2% YoY -8.7% QoQ
361
17.6% YoY 43.8% QoQ
2024 96
-68.8% YoY -73.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and EMPAVELI search interestLast update: February 09 2024 15:36:11.
Correlation coefficient between keyword and revenue is -0.06
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 15:36:14.

The average 5 years interest of EMPAVELI was 14.62 per week.
The last year interest of EMPAVELI compared to the last 5 years has changed by 54.31%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 313.19%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 15:36:18.

After 39 days of this quarter the interest is at 195.0. Based on that we can calculate that during remaining 52 days it will total up to 455.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
20190
16
inf% QoQ
5
-68.8% QoQ
28
460.0% QoQ
2020 12
inf% YoY -57.1% QoQ
16
0.0% YoY 33.3% QoQ
6
20.0% YoY -62.5% QoQ
25
-10.7% YoY 316.7% QoQ
2021 43
258.3% YoY 72.0% QoQ
10
-37.5% YoY -76.7% QoQ
14
133.3% YoY 40.0% QoQ
11
-56.0% YoY -21.4% QoQ
2022 26
-39.5% YoY 136.4% QoQ
15
50.0% YoY -42.3% QoQ
30
114.3% YoY 100.0% QoQ
38
245.5% YoY 26.7% QoQ
2023 421
1519.2% YoY 1007.9% QoQ
731
4773.3% YoY 73.6% QoQ
620
1966.7% YoY -15.2% QoQ
444
1068.4% YoY -28.4% QoQ
2024 195
-53.7% YoY -56.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and SYFOVRE search interestLast update: February 09 2024 15:36:17.
Correlation coefficient between keyword and revenue is 0.19
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 15:36:20.

The average 5 years interest of SYFOVRE was 10.37 per week.
The last year interest of SYFOVRE compared to the last 5 years has changed by 343.78%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 4241.51%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for APL-2006 to provide analysis

Correlation between past revenue and APL-2006 search interest

There is not enough data for APL-2006 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for APL-2006 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for C3 inhibitor to provide analysis

Correlation between past revenue and C3 inhibitor search interest

There is not enough data for C3 inhibitor to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for C3 inhibitor to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for complement system inhibition to provide analysis

Correlation between past revenue and complement system inhibition search interest

There is not enough data for complement system inhibition to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for complement system inhibition to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 15:36:25.

After 39 days of this quarter the interest is at 172.0. Based on that we can calculate that during remaining 52 days it will total up to 401.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019438
554
26.5% QoQ
616
11.2% QoQ
620
0.6% QoQ
2020 817
86.5% YoY 31.8% QoQ
599
8.1% YoY -26.7% QoQ
561
-8.9% YoY -6.3% QoQ
503
-18.9% YoY -10.3% QoQ
2021 442
-45.9% YoY -12.1% QoQ
382
-36.2% YoY -13.6% QoQ
385
-31.4% YoY 0.8% QoQ
333
-33.8% YoY -13.5% QoQ
2022 406
-8.1% YoY 21.9% QoQ
382
0.0% YoY -5.9% QoQ
352
-8.6% YoY -7.9% QoQ
372
11.7% YoY 5.7% QoQ
2023 428
5.4% YoY 15.1% QoQ
419
9.7% YoY -2.1% QoQ
394
11.9% YoY -6.0% QoQ
418
12.4% YoY 6.1% QoQ
2024 172
-59.8% YoY -58.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and autoimmune diseases search interestLast update: February 09 2024 15:36:24.
Correlation coefficient between keyword and revenue is 0.35
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 15:36:27.

The average 5 years interest of autoimmune diseases was 36.75 per week.
The last year interest of autoimmune diseases compared to the last 5 years has changed by -13.77%.
The interest for autoimmune diseases is seasonal.
The last year interest is quite lower compared to 5 years ago. It has decreased by -33.23%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 15:36:32.

After 39 days of this quarter the interest is at 185.0. Based on that we can calculate that during remaining 52 days it will total up to 432.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019285
394
38.2% QoQ
326
-17.3% QoQ
321
-1.5% QoQ
2020 354
24.2% YoY 10.3% QoQ
413
4.8% YoY 16.7% QoQ
378
16.0% YoY -8.5% QoQ
362
12.8% YoY -4.2% QoQ
2021 375
5.9% YoY 3.6% QoQ
373
-9.7% YoY -0.5% QoQ
347
-8.2% YoY -7.0% QoQ
328
-9.4% YoY -5.5% QoQ
2022 452
20.5% YoY 37.8% QoQ
436
16.9% YoY -3.5% QoQ
363
4.6% YoY -16.7% QoQ
504
53.7% YoY 38.8% QoQ
2023 449
-0.7% YoY -10.9% QoQ
482
10.6% YoY 7.3% QoQ
440
21.2% YoY -8.7% QoQ
493
-2.2% YoY 12.0% QoQ
2024 185
-58.8% YoY -62.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and inflammatory diseases search interestLast update: February 09 2024 15:36:32.
Correlation coefficient between keyword and revenue is -0.11
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 15:36:34.

The average 5 years interest of inflammatory diseases was 30.88 per week.
The last year interest of inflammatory diseases compared to the last 5 years has changed by 15.97%.
The interest for inflammatory diseases is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 27.3%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for APLS
Earnings date: 2024-02-26 After close
Company name: Apellis Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T12:35:00Z

GlobeNewswire
Biogen Completes Acquisition of Apellis Pharmaceuticals

2026-04-20T18:59:00-04:00

PR Newswire
Are CCO, EHAB, APLS, VRE Obtaining Fair Deals for their Shareholders?

2026-04-17T13:08:15Z

Analyst Upgrades
Wells Fargo Downgrades Apellis Pharmaceuticals to Equal-Weight, Raises Price Target to $41

2026-04-14T16:15:00-04:00

PR Newswire
Are GSAT, APLS, FORA Obtaining Fair Deals for their Shareholders?

2026-04-10T13:34:00-04:00

PR Newswire
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?

2026-04-08T14:15:00-04:00

PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS

2026-04-07T14:48:00-04:00

PR Newswire
Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders?

2026-04-02T12:14:42Z

Analyst Upgrades
Mizuho Maintains Neutral on Apellis Pharmaceuticals, Raises Price Target to $41

2026-04-01T16:07:00-04:00

PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)

2026-04-01T19:31:51Z

Analyst Upgrades
JP Morgan Downgrades Apellis Pharmaceuticals to Neutral, Raises Price Target to $41

2026-04-01T17:57:51Z

Analyst Upgrades
Barclays Maintains Equal-Weight on Apellis Pharmaceuticals, Raises Price Target to $41

2026-04-01T14:21:11Z

Analyst Upgrades
Raymond James Downgrades Apellis Pharmaceuticals to Market Perform

2026-04-01T14:14:25Z

Analyst Upgrades
This PPG Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

2026-04-01T13:29:22Z

Analyst Upgrades
Citigroup Downgrades Apellis Pharmaceuticals to Neutral, Lowers Price Target to $41

2026-04-01T11:17:02Z

Analyst Upgrades
HC Wainwright & Co. Downgrades Apellis Pharmaceuticals to Neutral, Lowers Price Target to $41